Author Archive: Tracy Cooley

Tracy Cooley

Tracy serves as the Director of Events Communications and handles all communications for BIO’s events and emerging company policy issues. She loves blogging and podcasting on all things biotech and believes in the great potential of the industry, looking for every opportunity to spread the message far and wide. Nearly everyone in her family is a golfer, and as such, she has what many people have called a “natural” swing. Sometimes she even hits the ball. Tracy just finished her ninth marathon, and has nearly mastered the skill of one-foot-in-front-of-the-other (usually, sometimes the laces get in the way). The joy of her life is her five-year-old daughter Josephine.

Latest Posts

Washington Post: Crowdsourcing Medical Decisions

clinical-trial-article-115x76

On Monday, Ariana Eunjung Cha wrote about the difficult ethical issue of Compassionate Use, which allows a patient access to an unapproved treatment when others with similar requests are denied access. Arthur Caplan, director of the division of medical ethics at New York University’s Langone Medical Center, describes it as a moral dilemma that could not be ‘more troubling and impossible-to-resolve’. In the article, Caplan asserts that ‘it’s best for the company to focus on getting the Read More >

Health  |  1 Comment  |  Email This Post
Tags: , , , , , ,

AIR 340B: New Analysis Shows Most 340B Hospitals Provide Little Charity Care

95468934

Today, the Alliance for Integrity and Reform of 340B (AIR 340B) released a new report, showing that a substantial portion of hospitals enrolled in the 340B drug discount program provide only the barest amount of charity care, and as such they are not fulfilling Congress’ expectations about the program. Congress created the program in 1992 to help uninsured indigent patients gain better access to prescription medicines. The original intention of the program was to provide Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Vaccines: Cold Case

Copyright sanofi pasteur

At the upcoming BIO International Convention, vaccines experts will come together to discuss key infectious diseases for which preventive vaccines have eluded researchers.  Panelists will discuss two “cold case” diseases where vaccines are currently in development.  Panelists will share new information related to respiratory syncytial virus (RSV) and dengue fever vaccines.  The panel will review the ‘lessons learned,’ the impact new technologies have had on conquering these diseases and examine the recent efforts to develop Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Promising News for Babies Born HIV-Positive

kids

This week, scientists announced that they have cleared HIV in a Long Beach, Calif.-baby who doctors confirmed was infected with the virus at the time of birth. Last year, doctors reported that a baby in Mississippi had been cleared of the virus after receiving aggressive drug treatment 30 hours after birth. The most recent announcement is particularly significant because the latest baby was confirmed to have the virus and doctors immediately started the baby on Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Partnership for Part D Access Launches Today

BIO-logo-115x76

BIO joins patient groups and other health care stakeholders today to announce the formation of the Partnership for Part D Access, a coalition committed to protecting access to necessary medications for patients in the Medicare Part D prescription drug program. The Partnership for Part D Access opposes a proposed rule from the U.S. Centers for Medicare & Medicaid Services (CMS) that would reduce the number of “protected classes” of medication in Medicare Part D, specifically Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,